Predictive Factors of Lamivudine Treatment Success in a Hepatitis B Virus-Infected Pediatric Cohort: A 10-Year Study
BACKGROUND: Hepatitis B virus (HBV) infections are responsible for the development of chronic hepatitis in 400 million people worldwide. Currently, no consensus exists as to when treatment should be initiated for pediatric patients.
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/2012/928912 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832561717974925312 |
---|---|
author | Yasmine Yousef Kathie Béland Emmanuel Mas Pascal Lapierre Dorothée Bouron Dal Soglio Fernando Alvarez |
author_facet | Yasmine Yousef Kathie Béland Emmanuel Mas Pascal Lapierre Dorothée Bouron Dal Soglio Fernando Alvarez |
author_sort | Yasmine Yousef |
collection | DOAJ |
description | BACKGROUND: Hepatitis B virus (HBV) infections are responsible for the development of chronic hepatitis in 400 million people worldwide. Currently, no consensus exists as to when treatment should be initiated for pediatric patients. |
format | Article |
id | doaj-art-8b89843fc69e4ca7bdfcff8a438d4f96 |
institution | Kabale University |
issn | 0835-7900 |
language | English |
publishDate | 2012-01-01 |
publisher | Wiley |
record_format | Article |
series | Canadian Journal of Gastroenterology |
spelling | doaj-art-8b89843fc69e4ca7bdfcff8a438d4f962025-02-03T01:24:25ZengWileyCanadian Journal of Gastroenterology0835-79002012-01-0126742943510.1155/2012/928912Predictive Factors of Lamivudine Treatment Success in a Hepatitis B Virus-Infected Pediatric Cohort: A 10-Year StudyYasmine Yousef0Kathie Béland1Emmanuel Mas2Pascal Lapierre3Dorothée Bouron Dal Soglio4Fernando Alvarez5Division of Gastroenterology, Hepatology and Nutrition, CHU Sainte-Justine, Montreal, Quebec, CanadaDivision of Gastroenterology, Hepatology and Nutrition, CHU Sainte-Justine, Montreal, Quebec, CanadaDivision of Gastroenterology, Hepatology, Nutrition and Diabetology, Children’s Hospital, Toulouse, FranceDivision of Gastroenterology, Hepatology and Nutrition, CHU Sainte-Justine, Montreal, Quebec, CanadaDivision of Pathology, CHU Sainte-Justine, CanadaDivision of Gastroenterology, Hepatology and Nutrition, CHU Sainte-Justine, Montreal, Quebec, CanadaBACKGROUND: Hepatitis B virus (HBV) infections are responsible for the development of chronic hepatitis in 400 million people worldwide. Currently, no consensus exists as to when treatment should be initiated for pediatric patients.http://dx.doi.org/10.1155/2012/928912 |
spellingShingle | Yasmine Yousef Kathie Béland Emmanuel Mas Pascal Lapierre Dorothée Bouron Dal Soglio Fernando Alvarez Predictive Factors of Lamivudine Treatment Success in a Hepatitis B Virus-Infected Pediatric Cohort: A 10-Year Study Canadian Journal of Gastroenterology |
title | Predictive Factors of Lamivudine Treatment Success in a Hepatitis B Virus-Infected Pediatric Cohort: A 10-Year Study |
title_full | Predictive Factors of Lamivudine Treatment Success in a Hepatitis B Virus-Infected Pediatric Cohort: A 10-Year Study |
title_fullStr | Predictive Factors of Lamivudine Treatment Success in a Hepatitis B Virus-Infected Pediatric Cohort: A 10-Year Study |
title_full_unstemmed | Predictive Factors of Lamivudine Treatment Success in a Hepatitis B Virus-Infected Pediatric Cohort: A 10-Year Study |
title_short | Predictive Factors of Lamivudine Treatment Success in a Hepatitis B Virus-Infected Pediatric Cohort: A 10-Year Study |
title_sort | predictive factors of lamivudine treatment success in a hepatitis b virus infected pediatric cohort a 10 year study |
url | http://dx.doi.org/10.1155/2012/928912 |
work_keys_str_mv | AT yasmineyousef predictivefactorsoflamivudinetreatmentsuccessinahepatitisbvirusinfectedpediatriccohorta10yearstudy AT kathiebeland predictivefactorsoflamivudinetreatmentsuccessinahepatitisbvirusinfectedpediatriccohorta10yearstudy AT emmanuelmas predictivefactorsoflamivudinetreatmentsuccessinahepatitisbvirusinfectedpediatriccohorta10yearstudy AT pascallapierre predictivefactorsoflamivudinetreatmentsuccessinahepatitisbvirusinfectedpediatriccohorta10yearstudy AT dorotheebourondalsoglio predictivefactorsoflamivudinetreatmentsuccessinahepatitisbvirusinfectedpediatriccohorta10yearstudy AT fernandoalvarez predictivefactorsoflamivudinetreatmentsuccessinahepatitisbvirusinfectedpediatriccohorta10yearstudy |